New Key Statistics Module, Z-Score and F-Score
NAS:SAGE Key Ratios
| Market Cap $ M | 350.52 |
| Enterprise Value $ M | -223.65 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.64 |
| Price/Sales | 3.24 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 106.00 |
| EPS (TTM) $ | -5.57 |
| Beneish M-Score | 4.24 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.60 |
| EV-to-EBITDA | 0.60 |
| PEG | -- |
| Shares Outstanding M | 61.17 |
| Net Margin (%) | -317.29 |
| Operating Margin % | -350.06 |
| Pre-tax Margin (%) | -317.29 |
| Quick Ratio | 10.02 |
| Current Ratio | 10.02 |
| ROA % (ttm) | -43.07 |
| ROE % (ttm) | -48.20 |
| ROIC % (ttm) | -962.91 |
| Dividend Yield % | -- |
| Altman Z-Score | -4.06 |
SAGE Number of Guru Trades
SAGE Volume of Guru Trades
Gurus Latest Trades with NAS:SAGE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SAGE is held by these investors
Total 2
Sage Therapeutics Inc Insider Transactions
No Available Data
News about NAS:SAGE
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers